Redefining the role of etoposide in first-line treatment of peripheral T-cell lymphoma
Abstract: Peripheral T-cell lymphomas (PTCLs) have an aggressive biological course and poor clinical outcomes. Despite producing somewhat less-than-satisfactory results, the combination of cyclophosphamide, doxorubicin, vincristine, and prednisone (CHOP) remains the de facto standard in PTCL treatme...
Salvato in:
| Autori principali: | , , , , , , , |
|---|---|
| Natura: | Artigo |
| Lingua: | Inglês |
| Pubblicazione: |
Elsevier
2017-11-01
|
| Serie: | Blood Advances |
| Accesso online: | http://www.sciencedirect.com/science/article/pii/S2473952920301270 |
| Tags: |
Nessun Tag, puoi essere il primo ad aggiungerne!!
|